Skip to content

Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.

Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.

Published on

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds

The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds

Published on

A new Stanford-led study catalogs the prevalence and types of deception by volunteers in clinical trials and suggests ways for investigators to root it out.

A new Stanford-led study catalogs the prevalence and types of deception by volunteers in clinical trials and suggests ways for investigators to root it out.

Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.

Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.

In this video, Stanford Medicine heart surgeon Joseph Woo discusses his award-winning research that examined the pros of cons of mechanical versus biological valve replacements.

In this video, Stanford Medicine heart surgeon Joseph Woo discusses his award-winning research that examined the pros of cons of mechanical versus biological valve replacements.

Published on

A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.

A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.

Published on